Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Volume 56, Number 4, February 27, 2001
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Terreni, L.
Right arrow Articles by Mariani, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Terreni, L.
Right arrow Articles by Mariani, C.
Related Collections
Right arrow Parkinson's disease/Parkinsonism
Right arrow All Genetics
Neurology 2001;56:463-466
© 2001 American Academy of Neurology


Articles

New mutation (R42P) of the parkin gene in the ubiquitinlike domain associated with parkinsonism

L. Terreni, PhD;, E. Calabrese, MD;, A.M. Calella, PhD;, G. Forloni, PhD; and C. Mariani, MD

From the Biology of Neurodegenerative Disorders Laboratory (Drs. Terreni, Calella, and Forloni), Istituto di Ricerche, Farmacologiche "Mario Negri"; and IRCCS S. Maria Nascente (Dr. Calabrese) and Department of Neurology (Dr. Mariani), Ospedale L. Sacco, Milan, Italy.

Address correspondence and reprint requests to Dr. Gianluigi Forloni, Istituto di Ricerche Farmacologiche "Mario Negri," Via Eritrea 62, 20157 Milan, Italy; e-mail: forloni{at}marionegri.it

OBJECTIVE: To investigate the association between parkin gene mutations and parkinsonism in an Italian family in which three of 12 siblings born to first-degree consanguineous parents had early-onset parkinsonism.

BACKGROUND: Several deleting or truncating mutations as well as missense mutations of the parkin gene were associated with early-onset parkinsonism.

METHOD: Three brothers were examined clinically at several stages of the disease. Single-strand conformational polymorphism analysis was done on the parkin gene of 32 members of the family. Samples showing mobility shifts were considered for mutation analysis.

RESULTS: Direct DNA sequencing revealed a novel homozygous amino acid substitution, Arg42Pro, in all three patients compared with a control DNA sample. The mutation occurred in the ubiquitinlike domain at the N-terminal of the protein. The patients did not display the clinical hallmarks previously seen with parkin mutations and were indistinguishable from patients with sporadic PD.

CONCLUSIONS: These findings confirm the recessive character of parkin mutations causing early-onset parkinsonism and the essential role of the ubiquitinlike region, highly conserved among species, and in accordance with the proposed parkin function.




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
C. Hampe, H. Ardila-Osorio, M. Fournier, A. Brice, and O. Corti
Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity
Hum. Mol. Genet., July 1, 2006; 15(13): 2059 - 2075.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. R. Sriram, X. Li, H. S. Ko, K. K.K. Chung, E. Wong, K. L. Lim, V. L. Dawson, and T. M. Dawson
Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin
Hum. Mol. Genet., September 1, 2005; 14(17): 2571 - 2586.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
H. C. Ardley, G. B. Scott, S. A. Rose, N. G. S. Tan, A. F. Markham, and P. A. Robinson
Inhibition of Proteasomal Activity Causes Inclusion Formation in Neuronal and Non-Neuronal Cells Overexpressing Parkin
Mol. Biol. Cell, November 1, 2003; 14(11): 4541 - 4556.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. C. Tsai, P. S. Fishman, N. V. Thakor, and G. A. Oyler
Parkin Facilitates the Elimination of Expanded Polyglutamine Proteins and Leads to Preservation of Proteasome Function
J. Biol. Chem., June 6, 2003; 278(24): 22044 - 22055.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
S. Thobois, M.-J. Ribeiro, E. Lohmann, A. Durr, P. Pollak, O. Rascol, S. Guillouet, E. Chapoy, N. Costes, Y. Agid, et al.
Young-Onset Parkinson Disease With and Without Parkin Gene Mutations: A Fluorodopa F 18 Positron Emission Tomography Study
Arch Neurol, May 1, 2003; 60(5): 713 - 718.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
H. Shimura, M. G. Schlossmacher, N. Hattori, M. P. Frosch, A. Trockenbacher, R. Schneider, Y. Mizuno, K. S. Kosik, and D. J. Selkoe
Ubiquitination of a New Form of alpha -Synuclein by Parkin from Human Brain: Implications for Parkinson's Disease
Science, July 13, 2001; 293(5528): 263 - 269.
[Abstract] [Full Text]